Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000654108 | SCV000775998 | likely benign | Charcot-Marie-Tooth disease type 4 | 2025-01-26 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002424544 | SCV002740666 | uncertain significance | Inborn genetic diseases | 2023-06-05 | criteria provided, single submitter | clinical testing | The c.2552G>A (p.R851Q) alteration is located in exon 11 (coding exon 11) of the SH3TC2 gene. This alteration results from a G to A substitution at nucleotide position 2552, causing the arginine (R) at amino acid position 851 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Genesis Genome Database | RCV000654108 | SCV000999725 | uncertain significance | Charcot-Marie-Tooth disease type 4 | 2019-08-14 | no assertion criteria provided | research | |
Prevention |
RCV004732985 | SCV005367557 | uncertain significance | SH3TC2-related disorder | 2024-08-14 | no assertion criteria provided | clinical testing | The SH3TC2 c.2552G>A variant is predicted to result in the amino acid substitution p.Arg851Gln. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.048% of alleles in individuals of Latino descent in gnomAD. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. |